Bristol-Myers Squibb pushes BuSpar compliance.
D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001007:Anxiety / Q000188:drug therapy* / Q000191:economics; D002065:Buspirone / Q000627:therapeutic use*; D004345:Drug Industry / Q000379:methods*; D006801:Humans; D010349:Patient Compliance; D010817:Physician-Patient Relations; D013685:Telecommunications / Q000458:organization & administration*; D014481:United States
D014151:Anti-Anxiety Agents; D002065:Buspirone